MNOV

Quote

Short

News

Articles

Message Board

Expected earnings - MediciNova Inc.

August 14, 2025 05:31:21 am

Source: US Earnings Reports

MediciNova Inc. (MNOV) is expected to report $-0.07 for Q2 2025

MediciNova Inc.

NASDAQ: MNOV

MNOV Trading

-0.72% G/L:

$1.37 Last:

2,419 Volume:

$1.3701 Open:

mwn-link-x Ad 300

MNOV Latest News

January 29, 2026 06:00:00 pm

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN?166 (ibudilast) in ALS patients

January 06, 2026 09:00:00 am

2026 New Year's Greetings from the CEO

December 18, 2025 06:00:00 am

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

December 08, 2025 06:00:00 am

MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND

MNOV Stock Data

Market Cap $81,091,306

Float 42,462,357

Insiders Ownership 0.12%

Institutions 11

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.medicinova.com

Country US

City La Jolla

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App